| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $631K | -27.0% | — |
| Cost of Revenue | $457K | -26.7% | — |
| Gross Profit | $174K | -27.8% | — |
| R&D Expense | $518K | -60.1% | -36.5% |
| SG&A Expense | $4.5M | +128.3% | +228.7% |
| Operating Income | -$4.9M | -60.0% | -121.7% |
| Pre-tax Income | -$9.7M | +54.2% | +58.7% |
| Net Income | -$9.7M | +54.2% | +58.7% |
| EPS (Basic) | -$0.16 | +67.3% | +90.5% |
| EPS (Diluted) | -$0.16 | +67.3% | +90.5% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $287K | — | — |
| Inventory | $1.5M | +22.9% | — |
| Current Assets | $5.1M | +25.3% | — |
| Total Assets | $5.1M | +24.6% | — |
| Current Liabilities | $28.7M | +1.1% | — |
| Long-term Debt | $17.7M | +0.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.4M | — | — |
| Capital Expenditures | $16K | — | — |
| Investing Cash Flow | -$16K | — | — |
| Financing Cash Flow | $4.5M | — | — |
| Free Cash Flow | -$4.4M | — | — |
| Total Liabilities | $46.4M | +0.7% | — |
| Stockholders' Equity | -$41.3M | +1.7% | +80.2% |